IS5093A - Kínólín og kínasólín efnasambönd nytsamleg í meðferð, einkum til að meðhöndla góðkynja vefjaauka í blöðruhálskirtli - Google Patents

Kínólín og kínasólín efnasambönd nytsamleg í meðferð, einkum til að meðhöndla góðkynja vefjaauka í blöðruhálskirtli

Info

Publication number: IS5093A
Authority: IS; Iceland
Prior art keywords: treatment; quinoline; compounds useful; benign prostatic; prostatic hyperplasia
Prior art date: 1997-01-11

Application number

IS5093A

Other languages

English (en)

Other versions

IS2012B (is

Inventor

Nathan Abraham Fox David

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-01-11

Filing date

1999-06-25

Publication date

1999-06-25

1999-06-25 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

1999-06-25 Publication of IS5093A publication Critical patent/IS5093A/is

2005-05-13 Publication of IS2012B publication Critical patent/IS2012B/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IS5093A 1997-01-11 1999-06-25 Kínólín og kínasólín efnasambönd nytsamleg í meðferð, einkum til að meðhöndla góðkynja vefjaauka í blöðruhálskirtli IS2012B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9700504.5A GB9700504D0 (en)	1997-01-11	1997-01-11	Pharmaceutical compounds
PCT/EP1998/000143 WO1998030560A1 (en)	1997-01-11	1998-01-06	Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of begnin prostatic hyperplasia

Publications (2)

Publication Number	Publication Date
IS5093A true IS5093A (is)	1999-06-25
IS2012B IS2012B (is)	2005-05-13

Family

ID=10805838

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5093A IS2012B (is)	1997-01-11	1999-06-25	Kínólín og kínasólín efnasambönd nytsamleg í meðferð, einkum til að meðhöndla góðkynja vefjaauka í blöðruhálskirtli

Country Status (45)

Country	Link
US (4)	US6169093B1 (is)
EP (1)	EP0968208B1 (is)
JP (1)	JP3357677B2 (is)
KR (1)	KR100347472B1 (is)
CN (2)	CN1093858C (is)
AP (1)	AP819A (is)
AR (1)	AR010396A1 (is)
AT (1)	ATE242238T1 (is)
AU (1)	AU724990B2 (is)
BG (1)	BG63918B1 (is)
BR (1)	BR9807068A (is)
CA (1)	CA2277473C (is)
CZ (1)	CZ295580B6 (is)
DE (1)	DE69815313T2 (is)
DK (1)	DK0968208T3 (is)
DZ (1)	DZ2394A1 (is)
EA (1)	EA002851B1 (is)
ES (1)	ES2198695T3 (is)
GB (1)	GB9700504D0 (is)
HK (2)	HK1025327A1 (is)
HN (1)	HN1998000002A (is)
HR (1)	HRP980010B1 (is)
HU (1)	HUP0000942A3 (is)
ID (1)	ID21863A (is)
IL (1)	IL130762A (is)
IS (1)	IS2012B (is)
MA (1)	MA26465A1 (is)
MY (1)	MY119623A (is)
NO (1)	NO318609B1 (is)
NZ (1)	NZ336302A (is)
OA (1)	OA11074A (is)
PA (1)	PA8444301A1 (is)
PE (1)	PE44499A1 (is)
PL (1)	PL334678A1 (is)
PT (1)	PT968208E (is)
SA (1)	SA97180705B1 (is)
SI (1)	SI0968208T1 (is)
SK (1)	SK284779B6 (is)
TN (1)	TNSN98004A1 (is)
TR (1)	TR199901604T2 (is)
TW (1)	TW444013B (is)
UA (1)	UA62945C2 (is)
WO (1)	WO1998030560A1 (is)
YU (1)	YU31699A (is)
ZA (1)	ZA98166B (is)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9700504D0 (en)	1997-01-11	1997-02-26	Pfizer Ltd	Pharmaceutical compounds
GB9708917D0 (en) *	1997-05-01	1997-06-25	Pfizer Ltd	Compounds useful in therapy
IL141235A (en)	2000-02-09	2012-04-30	Novartis Int Pharm Ltd	Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia
GEP20043364B (en) *	2000-03-03	2004-03-10	Pfizer	4-Amino-6,7-Dimethoxy-2-(5-Methanesulfonamido-1,2,3,4- Tetrahydroisoquinol-2-Yl)-5-(2-Pyridyl) Quinazoline Mesylat And Polymorphs
EP1315714B1 (en)	2000-08-31	2005-11-09	F. Hoffmann-La Roche Ag	Quinazoline derivatives as alpha-1 adrenergic antagonists
US6900220B2 (en)	2001-01-02	2005-05-31	Syntex (U.S.A.) Llc	Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
EP1363899B1 (en) *	2001-01-02	2005-05-11	F.Hoffmann-La Roche Ag	Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
GB0112061D0 (en) *	2001-05-18	2001-07-11	Pfizer Ltd	Process for the production of quinazolines
US6734303B2 (en)	2001-05-18	2004-05-11	Pfizer Inc.	Process for the production of quinazolines
US7163696B2 (en)	2001-10-11	2007-01-16	Pfizer Inc.	Pharmaceutical formulations
GB0124455D0 (en) *	2001-10-11	2001-12-05	Pfizer Ltd	Pharmaceutical formulations
GB0206033D0 (en) *	2002-03-14	2002-04-24	Pfizer Ltd	Compounds useful in therapy
AU2003249212C1 (en)	2002-07-15	2011-10-27	Symphony Evolution, Inc.	Receptor-type kinase modulators and methods of use
GB0219961D0 (en)	2002-08-28	2002-10-02	Pfizer Ltd	Oxytocin inhibitors
GB0221582D0 (en) *	2002-09-17	2002-10-23	Pfizer Ltd	Method of treatment
GB0221579D0 (en) *	2002-09-17	2002-10-23	Pfizer Ltd	Combinations of atorvastatin and, adrenergic receptor antagonists
JP2006505625A (ja)	2002-09-26	2006-02-16	ファイザー・インク	Ｈｉｖ感染症を治療するためのピラゾールアミド
GB0225908D0 (en) *	2002-11-06	2002-12-11	Pfizer Ltd	Treatment of female sexual dysfunction
SI1572173T1 (sl)	2002-12-13	2010-08-31	Warner Lambert Co	Alfa-2-delta ligand za zdravljenje simptomov spodnjega dela sečil
JP2009513504A (ja) *	2003-07-02	2009-04-02	エフ．ホフマン−ラロシュアーゲー	５−置換キナゾリノン誘導体
US7291640B2 (en)	2003-09-22	2007-11-06	Pfizer Inc.	Substituted triazole derivatives as oxytocin antagonists
SI2392564T1 (sl) *	2003-09-26	2014-02-28	Exelixis, Inc.	c-Met modulatorji in postopki uporabe
WO2005089804A2 (en) *	2004-03-16	2005-09-29	Pfizer Limited	Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists
KR20050092519A (ko) *	2004-03-16	2005-09-22	화이자 인코포레이티드	아토르바스타틴 및 α1-아드레날린성 수용체 길항제의 조합
CN1950348A (zh)	2004-04-30	2007-04-18	沃尼尔·朗伯有限责任公司	治疗中枢神经系统障碍的取代的吗啉化合物
WO2008084493A2 (en) *	2007-01-09	2008-07-17	Unichem Laboratories Limited	A novel process for the preparation of 2-halo-4-aminoquinazolines
JP2009126785A (ja) *	2007-11-19	2009-06-11	Mitsubishi Gas Chem Co Inc	２−ヨード−３，４−ジメトキシベンゾニトリルの製造方法
JP2009126784A (ja) *	2007-11-19	2009-06-11	Mitsubishi Gas Chem Co Inc	２−ヨード−３，４−ジメトキシベンゾニトリルの製造方法。
CN110818633A (zh)	2009-01-16	2020-02-21	埃克塞里艾克西斯公司	一种苹果酸盐及其晶型
UA108618C2 (uk)	2009-08-07	2015-05-25		Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку
CN106458974B (zh) *	2014-03-24	2019-07-16	广东众生药业股份有限公司	作为smo抑制剂的喹啉衍生物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US875506A (en) *	1907-03-19	1907-12-31	Berry H Collins	Guiding attachment for penholders.
GB1390015A (en) *	1971-05-07	1975-04-09	Koninklijke Pharma Fab Nv	4-amino-quinazoline compounds
US4026894A (en) *	1975-10-14	1977-05-31	Abbott Laboratories	Antihypertensive agents
US4098788A (en) *	1977-06-20	1978-07-04	Bristol-Myers Company	Process for preparing quinazolines
US4656174A (en)	1982-07-24	1987-04-07	Pfizer Inc.	Quinoline therapeutic agents
GB8506174D0 (en)	1985-03-09	1985-04-11	Pfizer Ltd	4-amino-6 7-dimethoxy-2-piperazin-1-ylquinazoline derivatives
IT1270993B (it) *	1994-03-18	1997-05-26	Recordati Chem Pharm	Derivati chinzolilamminici attivi come alfa-antagonisti
NZ325248A (en) *	1995-12-23	1999-09-29	Pfizer Res & Dev	Quinoline and quinazoline compounds useful in therapy
GB9700504D0 (en)	1997-01-11	1997-02-26	Pfizer Ltd	Pharmaceutical compounds
GB9708917D0 (en) *	1997-05-01	1997-06-25	Pfizer Ltd	Compounds useful in therapy
GB9711650D0 (en)	1997-06-05	1997-07-30	Pfizer Ltd	Compounds useful in therapy

1997
- 1997-01-11 GB GBGB9700504.5A patent/GB9700504D0/en active Pending
- 1997-11-18 TW TW086117203A patent/TW444013B/zh not_active IP Right Cessation
- 1997-12-13 SA SA97180705A patent/SA97180705B1/ar unknown
1998
- 1998-01-05 HN HN1998000002A patent/HN1998000002A/es unknown
- 1998-01-05 PE PE1998000006A patent/PE44499A1/es not_active Application Discontinuation
- 1998-01-06 BR BR9807068-1A patent/BR9807068A/pt not_active Application Discontinuation
- 1998-01-06 PA PA19988444301A patent/PA8444301A1/es unknown
- 1998-01-06 KR KR1019997006241A patent/KR100347472B1/ko not_active IP Right Cessation
- 1998-01-06 AP APAP/P/1998/001175A patent/AP819A/en active
- 1998-01-06 ID IDW990660A patent/ID21863A/id unknown
- 1998-01-06 PT PT98904058T patent/PT968208E/pt unknown
- 1998-01-06 EP EP98904058A patent/EP0968208B1/en not_active Expired - Lifetime
- 1998-01-06 YU YU31699A patent/YU31699A/sh unknown
- 1998-01-06 TR TR1999/01604T patent/TR199901604T2/xx unknown
- 1998-01-06 ES ES98904058T patent/ES2198695T3/es not_active Expired - Lifetime
- 1998-01-06 DK DK98904058T patent/DK0968208T3/da active
- 1998-01-06 EA EA199900531A patent/EA002851B1/ru not_active IP Right Cessation
- 1998-01-06 AT AT98904058T patent/ATE242238T1/de not_active IP Right Cessation
- 1998-01-06 DE DE69815313T patent/DE69815313T2/de not_active Expired - Lifetime
- 1998-01-06 HU HU0000942A patent/HUP0000942A3/hu unknown
- 1998-01-06 AU AU62088/98A patent/AU724990B2/en not_active Ceased
- 1998-01-06 CZ CZ19992436A patent/CZ295580B6/cs not_active IP Right Cessation
- 1998-01-06 PL PL98334678A patent/PL334678A1/xx unknown
- 1998-01-06 US US09/341,228 patent/US6169093B1/en not_active Expired - Lifetime
- 1998-01-06 WO PCT/EP1998/000143 patent/WO1998030560A1/en active IP Right Grant
- 1998-01-06 IL IL13076298A patent/IL130762A/xx not_active IP Right Cessation
- 1998-01-06 CN CN98801748A patent/CN1093858C/zh not_active Expired - Fee Related
- 1998-01-06 NZ NZ336302A patent/NZ336302A/xx unknown
- 1998-01-06 CA CA002277473A patent/CA2277473C/en not_active Expired - Fee Related
- 1998-01-06 SK SK907-99A patent/SK284779B6/sk unknown
- 1998-01-06 JP JP53056598A patent/JP3357677B2/ja not_active Expired - Lifetime
- 1998-01-06 SI SI9830477T patent/SI0968208T1/xx unknown
- 1998-01-06 CN CNB011432918A patent/CN1191249C/zh not_active Expired - Fee Related
- 1998-01-07 MA MA24920A patent/MA26465A1/fr unknown
- 1998-01-07 TN TNTNSN98004A patent/TNSN98004A1/fr unknown
- 1998-01-08 HR HR980010A patent/HRP980010B1/xx not_active IP Right Cessation
- 1998-01-08 AR ARP980100091A patent/AR010396A1/es unknown
- 1998-01-09 MY MYPI98000094A patent/MY119623A/en unknown
- 1998-01-09 ZA ZA98166A patent/ZA98166B/xx unknown
- 1998-06-01 UA UA99073901A patent/UA62945C2/uk unknown
- 1998-06-07 DZ DZ980004A patent/DZ2394A1/xx active
1999
- 1999-06-25 IS IS5093A patent/IS2012B/is unknown
- 1999-07-07 BG BG103560A patent/BG63918B1/bg unknown
- 1999-07-08 OA OA9900152A patent/OA11074A/en unknown
- 1999-07-09 NO NO19993396A patent/NO318609B1/no unknown
2000
- 2000-06-02 US US09/586,503 patent/US6365599B1/en not_active Expired - Fee Related
- 2000-07-24 HK HK00104585A patent/HK1025327A1/xx not_active IP Right Cessation
2001
- 2001-11-13 US US10/007,753 patent/US6521629B2/en not_active Expired - Fee Related
2002
- 2002-12-13 US US10/318,902 patent/US6653302B2/en not_active Expired - Fee Related
2003
- 2003-09-17 HK HK03106677.4A patent/HK1054389B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69815313T2 (de)	2003-12-11
ZA98166B (en)	1999-07-09
EP0968208B1 (en)	2003-06-04
HK1054389A1 (en)	2003-11-28
PT968208E (pt)	2003-09-30
JP3357677B2 (ja)	2002-12-16
BR9807068A (pt)	2000-05-02
AP9801175A0 (en)	1998-01-31
DE69815313D1 (de)	2003-07-10
AP819A (en)	2000-04-03
CN1191249C (zh)	2005-03-02
BG103560A (en)	2000-06-30
CN1093858C (zh)	2002-11-06
CZ295580B6 (cs)	2005-08-17
WO1998030560A1 (en)	1998-07-16
AU724990B2 (en)	2000-10-05
DK0968208T3 (da)	2003-07-28
US6521629B2 (en)	2003-02-18
CN1403453A (zh)	2003-03-19
YU31699A (sh)	2001-07-10
US6169093B1 (en)	2001-01-02
HN1998000002A (es)	1999-01-08
HUP0000942A3 (en)	2002-06-28
HK1025327A1 (en)	2000-11-10
ID21863A (id)	1999-08-05
TNSN98004A1 (fr)	2005-03-15
MY119623A (en)	2005-06-30
OA11074A (en)	2002-03-13
SA97180705B1 (ar)	2005-12-26
NO318609B1 (no)	2005-04-18
PE44499A1 (es)	1999-05-06
CA2277473C (en)	2003-08-12
SI0968208T1 (en)	2003-10-31
EA199900531A1 (ru)	2000-02-28
NO993396D0 (no)	1999-07-09
KR100347472B1 (ko)	2002-08-07
HUP0000942A2 (hu)	2001-04-28
UA62945C2 (en)	2004-01-15
EP0968208A1 (en)	2000-01-05
EA002851B1 (ru)	2002-10-31
CN1243513A (zh)	2000-02-02
SK284779B6 (sk)	2005-11-03
IL130762A (en)	2005-12-18
US6653302B2 (en)	2003-11-25
HRP980010B1 (en)	2002-06-30
NZ336302A (en)	2000-08-25
SK90799A3 (en)	2001-03-12
US20020040028A1 (en)	2002-04-04
HK1054389B (zh)	2005-10-14
PL334678A1 (en)	2000-03-13
MA26465A1 (fr)	2004-12-20
KR20000070022A (ko)	2000-11-25
AR010396A1 (es)	2000-06-07
CZ9902436A3 (cs)	2000-10-11
JP2000507966A (ja)	2000-06-27
IS2012B (is)	2005-05-13
TR199901604T2 (xx)	1999-12-21
DZ2394A1 (fr)	2003-06-04
NO993396L (no)	1999-07-09
ATE242238T1 (de)	2003-06-15
HRP980010A2 (en)	1998-10-31
BG63918B1 (bg)	2003-06-30
PA8444301A1 (es)	2000-05-24
GB9700504D0 (en)	1997-02-26
TW444013B (en)	2001-07-01
US6365599B1 (en)	2002-04-02
IL130762A0 (en)	2001-01-28
US20030130259A1 (en)	2003-07-10
CA2277473A1 (en)	1998-07-16
AU6208898A (en)	1998-08-03
ES2198695T3 (es)	2004-02-01

Publication	Publication Date	Title
IS5093A (is)	1999-06-25	Kínólín og kínasólín efnasambönd nytsamleg í meðferð, einkum til að meðhöndla góðkynja vefjaauka í blöðruhálskirtli
DE60023982D1 (de)	2005-12-22	System zur Behandlung von benigner Prostatahyperplasie
DK0925069T3 (da)	2007-10-29	Anvendelse af Cetrorelix til behandling af godartet prostatahypertrofi og prostatacancer
IS4731A (is)	1998-04-29	Kínólín og kínazólín efnasambönd nytsamleg í meðferð
ATE264328T1 (de)	2004-04-15	Substituierte 3-cyano-(1.7), (1.5) und (1.8)naphthyridininhibitoren von tyrosin kinasen
NO20015516L (no)	2002-01-11	Preparater og anvendelser av ET743 for behandling av kreft
AU1657097A (en)	1997-10-02	Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
NO995518L (no)	2000-01-11	Arylsubstituerte piperaziner brukbare ved behandling av benign prostatisk hyperplasi
HK1030776A1 (en)	2001-05-18	Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
ZA982819B (en)	1999-10-04	Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogn receptor modulators.
AU9128998A (en)	1999-03-22	Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
ZA991319B (en)	2000-11-20	Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia.
EP1435913A4 (en)	2007-10-24	METHOD OF TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER BENCH PROSTATIC PATHOLOGIES
BR9608912A (pt)	1999-03-02	Agonistas de meletonina para o tratamento de hiperplasia prostática benigna
ECSP982362A (es)	1998-12-22	Compuestos de quinolina y quinazolina utiles en terapia
AU2003204320A1 (en)	2003-06-19	Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
GB9602903D0 (en)	1996-04-10	Conjugates useful in the treatment of benign prostatic hyperplasia
GB9810895D0 (en)	1998-07-22	Combination therapy for the treatment of benign prostatic hyperplasia